Researchers Halt Trials of Promising Sickle Cell Treatment
Just when it seemed that a new gene therapy for sickle cell disease was sailing toward success, the company developing the treatment found that two patients now have cancer and halted the trial. A patient who was treated five and a half years ago has developed myelodysplastic syndrome, a form of cancer that is often…
Details